{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-040005","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.675381+00:00","generated_at":"2026-06-05T23:18:30.221510+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biote settles founder litigation, to repurchase 18.4M shares for $76.9M at $4.17 each","bullets":["Repurchases 5.1M Class A shares and 13.3M Paired Interests from founder Donovitz for $76.9M total.","Average price $4.17 per share; payments spread over three years: $32.2M now, $15.1M, $19.1M, $10.5M.","Mutual release of all claims; founder advisory agreement terminated, two-year non-compete agreed.","Existing $20M share repurchase authorization remains separate and unchanged.","CEO says resolution ends costly litigation and the buyback is accretive to shareholder value."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-040005","json":"https://secwatch.observer/filing/0001193125-24-040005.json","markdown":"https://secwatch.observer/filing/0001193125-24-040005.md","text":"https://secwatch.observer/filing/0001193125-24-040005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524040005/0001193125-24-040005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524040005/d676367d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:18:30.221510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c38f6cdaff560360fbe327fc313f77fd97b76c0c","claim":"biote Corp. entered into Settlement Term Sheet with Dr. Gary S. Donovitz valued at approximately $76.9 million (effective 2024-02-13).","evidence_excerpt":"On February 13, 2024, biote Corp., a Delaware corporation (the “Company”) entered into a binding settlement term sheet (the “Settlement Term Sheet”) with respect to its previously disclosed litigation with one of the Company’s stockholders, Dr. Gary S. Donovitz (“Donovitz”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524040005/0001193125-24-040005-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Dr. Gary S. Donovitz"},{"label":"Value","value":"approximately $76.9 million"},{"label":"Effective","value":"2024-02-13"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}